Genetel Pharmaceuticals (Shenzhen) Co., Ltd. ,locatedat Shenzhen Hi-tech Industrial Park in Nanshan District, is a wholly owned subsidiary of Genetel Pharmaceuticals Limited and is one of the top biotechnology companies in Shenzhen.

Genetel, as a platform for biotechnology intellectual property transfer and technology commercialization for City University of Hong Kong, has strong research background in developing modern biotechnology that benefits to the general public. The biotechnologies and products development based on the foundation of the innovative genomic and microarray technology (partially supported by China Ministry of Science and Technology "863 Program") has generated 23 US and PRC patent applications and patents. Genetel develops, produces and sells in vitro diagnostic kits, new drugs with protection by our own proprietary technology and patents.

Genetel owns GMP manufacturing facilities and has passed ISO9001:2000 Quality Management System authentication and ISO13485:2003 Medical Devices Quality Management System authentication.

The major products at the current stage are:

In vitro Molecular Diagnostic Kits:
Fluorescent real-time PCR detection kit for high/low-risk Human Papillomavirus (HPV)
PCR Micro-plate hybrid capture detection kit for Human Papillomavirus (HPV)
HPV genotyping detection system (kit and instrument)
Fluorescent real-time PCR detection kit for Hepatitis B virus (HBV)

New Drugs:
Recombinant Human Augmenter of Liver Regeneration (rhALR)
Recombinant Human Interleukin-10 (rhIL-10)
Novel Pt-related anti-tumor drugs
Novel natural anti-tumor chemicals
Novel natural anti-osteoporosis compound

To provide the society with first class technology, products and services for diagnosing , preventing and treating disease is our aim.